Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Site-Targeted Drug Delivery Systems: Polymeric Carriers01:24

Site-Targeted Drug Delivery Systems: Polymeric Carriers

Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...
Modified-Release Drug Delivery Systems: Site-Targeted01:24

Modified-Release Drug Delivery Systems: Site-Targeted

Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Star-shaped PCL nanoparticles combining quercetin release and α-amylase surface functionalization enable AFM-quantified removal of biofilms of clinical Staphylococcus aureus isolates.

Biomaterials advances·2026
Same author

Quantitative single-cell analysis of PML-RARα oncogene-induced DNA damage along cell cycle progression.

Methods (San Diego, Calif.)·2026
Same author

Advancing Italian biophysics: insights from the 27th SIBPA congress.

European biophysics journal : EBJ·2026
Same author

Antisecretory Factor in rat cerebellar granule cells augments inhibitory current via GABA<sub>A</sub> receptors: a mechanism for vertigo reduction in Menière's disease?

European biophysics journal : EBJ·2026
Same author

Wavefront estimation through structured detection in laser scanning microscopy.

Biomedical optics express·2026
Same author

Engineered biopolymeric hydrogels for in vitro modeling of equine sarcoid tumors in comparative oncology.

International journal of biological macromolecules·2026

Related Experiment Video

Updated: Jun 4, 2026

Encapsulated Cell Technology for the Delivery of Biologics to the Mouse Eye
06:10

Encapsulated Cell Technology for the Delivery of Biologics to the Mouse Eye

Published on: March 30, 2020

Collagen containing microcapsules: smart containers for disease controlled therapy.

Laura Pastorino1, Svetlana Erokhina, Federico Caneva Soumetz

  • 1Department of Communication, Computer and System Sciences, University of Genova, Via all'Opera Pia 13, 16145 Genova, Italy. laura.pastorino@unige.it

Journal of Colloid and Interface Science
|February 26, 2011
PubMed
Summary

Researchers developed collagen-based microcapsules for drug delivery. These capsules release medication on demand, triggered by matrix metalloproteinases associated with pathological conditions.

More Related Videos

Recombinant Collagen I Peptide Microcarriers for Cell Expansion and Their Potential Use As Cell Delivery System in a Bioreactor Model
08:43

Recombinant Collagen I Peptide Microcarriers for Cell Expansion and Their Potential Use As Cell Delivery System in a Bioreactor Model

Published on: February 7, 2018

Encapsulation Thermogenic Preadipocytes for Transplantation into Adipose Tissue Depots
08:30

Encapsulation Thermogenic Preadipocytes for Transplantation into Adipose Tissue Depots

Published on: June 2, 2015

Related Experiment Videos

Last Updated: Jun 4, 2026

Encapsulated Cell Technology for the Delivery of Biologics to the Mouse Eye
06:10

Encapsulated Cell Technology for the Delivery of Biologics to the Mouse Eye

Published on: March 30, 2020

Recombinant Collagen I Peptide Microcarriers for Cell Expansion and Their Potential Use As Cell Delivery System in a Bioreactor Model
08:43

Recombinant Collagen I Peptide Microcarriers for Cell Expansion and Their Potential Use As Cell Delivery System in a Bioreactor Model

Published on: February 7, 2018

Encapsulation Thermogenic Preadipocytes for Transplantation into Adipose Tissue Depots
08:30

Encapsulation Thermogenic Preadipocytes for Transplantation into Adipose Tissue Depots

Published on: June 2, 2015

Area of Science:

  • Biomaterials Science
  • Drug Delivery Systems
  • Tissue Engineering

Background:

  • Collagen is a key connective tissue protein vital for biological functions.
  • Degradation of collagen is implicated in various pathological processes, often involving matrix metalloproteinases (MMPs).
  • Controlled drug release systems are needed to target pathological conditions effectively.

Purpose of the Study:

  • To fabricate collagen-based microcapsules for drug encapsulation.
  • To achieve drug release modulated by cellular demand via matrix metalloproteinase action.
  • To develop a responsive drug delivery system based on collagen and MMPs.

Main Methods:

  • Fabrication of collagen type I microcapsules using layer-by-layer assembly with poly(styrene sulfonate).
  • Characterization of shell growth using quartz crystal microbalance and X-ray reflectivity.
  • Morphological analysis via scanning electron microscopy and permeability studies using Confocal Laser Scanning Microscopy.
  • Investigation of matrix metalloproteinase 1 interaction with collagen films.

Main Results:

  • Successfully fabricated hollow collagen-based microcapsules.
  • Demonstrated matrix metalloproteinase 1 mediated changes in capsule permeability.
  • Confirmed the interaction between matrix metalloproteinase 1 and collagen films.
  • Visualized MMP-1 mediated drug release variations.

Conclusions:

  • Collagen-based microcapsules can be fabricated for controlled drug delivery.
  • Drug release can be engineered to be dependent on the pathological biochemical environment.
  • This system offers a potential strategy for demand-based drug release in disease states.